Companies › BBLG

BONE BIOLOGICS CORP (BBLG)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001419554 · EDGAR filings · Updated 2026-07-24

BONE BIOLOGICS CORP (BBLG) has reported institutional ownership of 0.2%, with 2 institutional managers holding positions valued at $689.9K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (3)

• 2026-07-24 — EFFECT filed
• 2026-07-24 — Prospectus supplement (424B3) filed
• 2026-07-23 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — DEFA14A filed
• 2026-07-17 — Shelf registration (S-3) filed
• 2026-07-16 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BONE BIOLOGICS CORP has 2 institutional holders and institutional ownership of 0.2%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

ERNEXA THERAPEUTICS INC (ERNA) · INTELLIGENT BIO SOLUTIONS IN (INBS) · GENENTA SCIENCE S P A (GNTA) · Exicure Inc (XCUR) · P3 HEALTH PARTNERS INC (PIII) · Kiora Pharmaceuticals Inc (KPRX)